In addition, a study by Palomar-Abril et al. evaluated TNM stage III NSCLC patients by grouping them as under and over 70 years of age, where CRP levels were found to be significantly higher in the group over 70 years of age [15]. The gene discussed is CRP; the disease is non-small cell lung carcinoma.